NCT00027664View on ClinicalTrials.gov

Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer

PHASE2UnknownINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 28, 2001

Conditions
Kidney Cancer
Interventions
BIOLOGICAL

recombinant interferon alfa

DRUG

thalidomide

Trial Locations (3)

LS9 7TF

Leeds Cancer Centre at St. James's University Hospital, Leeds

0X3 9DU

Oxford Radcliffe Hospital, Oxford

G12 0YN

Beatson West of Scotland Cancer Centre, Glasgow

Sponsors

Lead Sponsor

Cancer Research UK
All Listed Sponsors
lead

Cancer Research UK

OTHER